ArticleMolecular therapy. Methods & clinical development2022

A first-in-human phase I/IIa gene transfer clinical trial for Duchenne muscular dystrophy using rAAVrh74.MCK.

Kevin M Flanigan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.